Gut Microbiome Composition Predicts Infection Risk During Chemotherapy in Children With Acute Lymphoblastic Leukemia
Hana Hakim, Jason W. Rosch(St. Jude Children's Research Hospital), Randall T. Hayden(St. Jude Children's Research Hospital), Elaine Tuomanen(St. Jude Children's Research Hospital), Ronald H. Dallas(St. Jude Children's Research Hospital), Sima Jeha(St. Jude Children's Research Hospital), Cydney N. Johnson(St. Jude Children's Research Hospital), Erik A. Karlsson(Institut Pasteur du Cambodge), Stanley Pounds(St. Jude Children's Research Hospital), Ti‐Cheng Chang(St. Jude Children's Research Hospital), Victoria R Darling(St. Jude Children's Research Hospital), Yilun Sun(St. Jude Children's Research Hospital), Stacey Schultz‐Cherry(St. Jude Children's Research Hospital), Li Tang(St. Jude Children's Research Hospital), Joshua Wolf(St. Jude Children's Research Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital)
Cited by 191
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k